These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 8769180
1. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Bruce DS, Newell KA, Woodle ES, Millis JM, Piper JB, Huss E, Thistlethwaite JR. Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180 [No Abstract] [Full Text] [Related]
2. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation. Cantarovich D, Giral M, Josien R, Karam G, Hourmant M, Dantal J, Blancho G, Soulillou JP. Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897 [No Abstract] [Full Text] [Related]
3. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation. Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P. Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207 [No Abstract] [Full Text] [Related]
4. Cyclosporine therapy in pancreas transplantation. Davidson I, Lu C, Melone D, Risser R. Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. el-Ghoroury M, Hariharan S, Peddi VR, Munda R, Schroeder TJ, Demmy AM, Alexander JW, First MR. Transplant Proc; 1997 Feb; 29(1-2):649-51. PubMed ID: 9123461 [No Abstract] [Full Text] [Related]
17. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years. MacDonell RC, Van Buren DH, Richie RE, Johnson HK, Nylander WA, Helderman JH, Ynares CM, Trusler LA, Green WF, Crowe DA. Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774 [No Abstract] [Full Text] [Related]